Javascript must be enabled to continue!
Abstract 4825: Metabolic factors and hepatocarcinogenesis in steatohepatitis.
View through CrossRef
Abstract
Background: With the rising prevalence in the US of alcoholism, obesity, and metabolic syndrome and better treatments for hepatitis B and C, steatohepatitis is projected to become the leading cause of end-stage liver disease and hepatocellular carcinoma (HCC) by 2025.
Objective, Setting, and Design: Using a prospectively collected database, we analyzed clinical and pathologic features of HCC in patients who underwent liver transplantation (LT) for steatohepatitis due to non-alcoholic (NASH) and alcoholic causes (ALD) between 1/1/02 and 12/31/11 in a large urban transplant center. We further compared patients with HCC due to NASH (N-HCC) and ALD (A-HCC).
Results: HCC was present in 80 of 317 patients who underwent LT for steatohepatitis with equivalent distribution in NASH and ALD patients (24% vs 26%;P=0.8). On multivariate analysis, age and diabetes were associated with HCC in the explant but not BMI, hypertension, or smoking; hyperlipidemia was protective (Table). Among patients with HCC, N-HCC patients were more likely than A-HCC patients to be female (58% vs 4%;P<0.0001) and have metabolic syndrome (27% vs 9%;P=0.025). On pathology, N-HCC patients were also more likely to have steatosis (76% vs 34%;P<0.001), steatohepatitis (67% vs 19%;P<0.0001), or nuclear grade 1 or 2 (89% vs 67%;P=0.03). Five-year survival was similar in N-HCC and A-HCC (67% vs 68%;P=1).
Conclusions: We report the largest series of liver transplantation for HCC in steatohepatitis. Metabolic factors such as diabetes and hyperlipidemia appear to play large and independent promoting and protective roles in hepatocarcinogenesis. Modulation of causative factors may be important in management of this increasingly common obesity-related disease.
Table. Multivariate Predictors of HCC Presence in Explant
Table. Multivariate Predictors of HCC Presence in Explant HR P Age > 60 y 2.07 0.002 Diabetes 1.64 0.04 Male gender 1.47 0.18 Hypertension 1.31 0.26 NASH etiology 0.93 0.77 Smoking 0.90 0.64 BMI > 35 kg/m2 0.71 0.30 Hyperlipidemia 0.33 0.02
Citation Format: Ali Zarrinpar, Vatche Agopian, Jonathan Hiatt, Ronald Busuttil. Metabolic factors and hepatocarcinogenesis in steatohepatitis. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4825. doi:10.1158/1538-7445.AM2013-4825
Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.
American Association for Cancer Research (AACR)
Title: Abstract 4825: Metabolic factors and hepatocarcinogenesis in steatohepatitis.
Description:
Abstract
Background: With the rising prevalence in the US of alcoholism, obesity, and metabolic syndrome and better treatments for hepatitis B and C, steatohepatitis is projected to become the leading cause of end-stage liver disease and hepatocellular carcinoma (HCC) by 2025.
Objective, Setting, and Design: Using a prospectively collected database, we analyzed clinical and pathologic features of HCC in patients who underwent liver transplantation (LT) for steatohepatitis due to non-alcoholic (NASH) and alcoholic causes (ALD) between 1/1/02 and 12/31/11 in a large urban transplant center.
We further compared patients with HCC due to NASH (N-HCC) and ALD (A-HCC).
Results: HCC was present in 80 of 317 patients who underwent LT for steatohepatitis with equivalent distribution in NASH and ALD patients (24% vs 26%;P=0.
8).
On multivariate analysis, age and diabetes were associated with HCC in the explant but not BMI, hypertension, or smoking; hyperlipidemia was protective (Table).
Among patients with HCC, N-HCC patients were more likely than A-HCC patients to be female (58% vs 4%;P<0.
0001) and have metabolic syndrome (27% vs 9%;P=0.
025).
On pathology, N-HCC patients were also more likely to have steatosis (76% vs 34%;P<0.
001), steatohepatitis (67% vs 19%;P<0.
0001), or nuclear grade 1 or 2 (89% vs 67%;P=0.
03).
Five-year survival was similar in N-HCC and A-HCC (67% vs 68%;P=1).
Conclusions: We report the largest series of liver transplantation for HCC in steatohepatitis.
Metabolic factors such as diabetes and hyperlipidemia appear to play large and independent promoting and protective roles in hepatocarcinogenesis.
Modulation of causative factors may be important in management of this increasingly common obesity-related disease.
Table.
Multivariate Predictors of HCC Presence in Explant
Table.
Multivariate Predictors of HCC Presence in Explant HR P Age > 60 y 2.
07 0.
002 Diabetes 1.
64 0.
04 Male gender 1.
47 0.
18 Hypertension 1.
31 0.
26 NASH etiology 0.
93 0.
77 Smoking 0.
90 0.
64 BMI > 35 kg/m2 0.
71 0.
30 Hyperlipidemia 0.
33 0.
02
Citation Format: Ali Zarrinpar, Vatche Agopian, Jonathan Hiatt, Ronald Busuttil.
Metabolic factors and hepatocarcinogenesis in steatohepatitis.
[abstract].
In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC.
Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4825.
doi:10.
1158/1538-7445.
AM2013-4825
Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.
Related Results
The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response
The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response
Abstract
Background & Aims
The clinical significance of steatohepatitis in chronic hepatitis B remains unclear. This ...
Abstract 1728: Overactivation of tumor suppressor P53 in hepatocytes promotes hepatocarcinogenesis
Abstract 1728: Overactivation of tumor suppressor P53 in hepatocytes promotes hepatocarcinogenesis
Abstract
Aim: p53 is a tumor suppressor and its dysfunction promotes carcinogenesis of several organs including the liver. Meanwhile, p53 is reported to be overac...
Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk
Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk
AbstractNonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. We prospectively evaluated endothelial function by assessing flow-mediated dilatation (...
TACE inhibition: a promising therapeutic intervention against AATF‐mediated steatohepatitis to hepatocarcinogenesis
TACE inhibition: a promising therapeutic intervention against AATF‐mediated steatohepatitis to hepatocarcinogenesis
Metabolic dysfunction‐associated steatohepatitis‐driven hepatocellular carcinoma (MASH‐HCC) is a global clinical challenge for which there is a limited understanding of disease pat...
Genotype networks, innovation, and robustness in sulfur metabolism
Genotype networks, innovation, and robustness in sulfur metabolism
Abstract
Background
A metabolism is a complex network of chemical reactions. This network synthesizes multiple small precursor molecules of bioma...
Metabolic syndrome and neuroprotection
Metabolic syndrome and neuroprotection
Introduction: over the years, the prevalence of metabolic syndrome has increased dramatically in developing countries as a major by-product of industrialization. Many factors, such...
Sleep-dependent modulation of metabolic rate in
Drosophila
Sleep-dependent modulation of metabolic rate in
Drosophila
Abstract
Dysregulation of sleep is associated with metabolic diseases, and metabolic rate is acutely regulated by sleep-wake behavior. In humans ...
Determinants of Metabolic Syndrome among Malaysian Government Employees
Determinants of Metabolic Syndrome among Malaysian Government Employees
Introduction: The metabolic syndrome comprises a collection of cardiovascular disease risks, which has been demonstrated to predict type 2 diabetes mellitus and cardiovascular dise...

